Evidence map›Paper›PMID 36437915›Full record

ArticleFrontiers in genetics2022

Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants.

Stefania Martone, Autilia Tommasina Buonagura, Roberta Marra, Barbara Eleni Rosato, Federica Del Giudice, Ferdinando Bonfiglio, Mario Capasso, Achille Iolascon, Immacolata Andolfo, Roberta Russo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Secondary Findings from Exome Sequencing of a Greek Cohort.Current issues in molecular biology · 2025
    Article
  5. Article
  6. Review
  7. A Novel De NovoGenes · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Stefania MartoneDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Autilia Tommasina BuonaguraDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Roberta MarraDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Barbara Eleni RosatoDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Federica Del GiudiceCEINGE Biotecnologie Avanzate, Napoli, Italy.
Ferdinando BonfiglioCEINGE Biotecnologie Avanzate, Napoli, Italy.
Mario CapassoDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Achille IolasconDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Immacolata AndolfoDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Roberta RussoDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
Ceinge Biotecnologie Avanzate (Italy) · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACMG actionable genesclinical exomegenetic testingNGS testingsecondary findings

Identifiers

PMID36437915
PMCPMC9685519
OpenAlexW4308868582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.